Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRTO

Proteon Therapeutics (PRTO) Stock Price, News & Analysis

Proteon Therapeutics logo

About Proteon Therapeutics Stock (NASDAQ:PRTO)

Advanced Chart

Key Stats

Today's Range
$2.80
$2.92
50-Day Range
$0.84
$25.13
52-Week Range
$0.22
$3.94
Volume
133,655 shs
Average Volume
1.11 million shs
Market Capitalization
$64.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PRTO Stock News Headlines

ProQR Therapeutics price target raised to $4 from $2.50 at Chardan
Protara Therapeutics (TARA) Earnings Dates & Reports
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
ProQR Therapeutics upgraded to Strong Buy from Outperform at Raymond James
ProQR Announces Major Share Offering Agreement
See More Headlines

PRTO Stock Analysis - Frequently Asked Questions

Proteon Therapeutics Inc (NASDAQ:PRTO) issued its quarterly earnings data on Thursday, October, 31st. The biopharmaceutical company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.09) by $0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that Proteon Therapeutics investors own include Bristol Myers Squibb (BMY), SCYNEXIS (SCYX), Agile Therapeutics (AGRX), ImmunoGen (IMGN), Onconova Therapeutics (ONTX), Sierra Oncology (SRRA) and Tonix Pharmaceuticals (TNXP).

Company Calendar

Last Earnings
10/31/2019
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PRTO
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.73 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.06) per share
Price / Book
-48.17

Miscellaneous

Free Float
N/A
Market Cap
$64.10 million
Optionable
Not Optionable
Beta
0.60
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:PRTO) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners